@FierceBiotech: ICYMI: Kite CEO Arie Belldegrun has a simple message for investors this morning: Relax. Story | Follow @FierceBiotech
@JohnCFierce: No surprise, coming off a $70M crossover, RegenX Bio files $100M. S-1/Report | Follow @JohnCFierce
> Sequencing giant Illumina ($ILMN) recruited Warburg Pincus, the Mayo Clinic and Sutter Hill Ventures to launch Helix, a consumer genomics company setting sail with $100 million from its founders. More
> Benitec Biopharma ($BNTC) pulled off a downsized IPO, raising just $13.8 million after pricing 1.5 million shares at $9.21 each. The company is developing gene-silencing treatments for hepatitis, cancer and age-related macular degeneration. News
Medical Device News
@FierceMedDev: UPDATED with comment from Fujifilm: FDA slaps three duodenoscope manufacturers with warning letters. Article | Follow @FierceMedDev
@EmilyWFierce: San Diego's Genalyte reeled in $44M in a Series C round for its microchip testing platform. Release | Follow @EmilyWFierce
> WSJ: New devices for rectal cancer surgery reduce need for colostomies. Story
> Illumina, LabCorp, Mayo Clinic, Warburg assemble to back latest consumer genomics entrant: Helix. Article
> FDA slaps three duodenoscope manufacturers with warning letters over related devices. Report
harma News
@FiercePharma: ICYMI yesterday: Will docs jump on new biosims? Survey shows they'll need some nudging. More | Follow @FiercePharma
@EricPFierce: Xellia decides it's best to have U.S. sales operations next to Raleigh, NC, plant it's expanding. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: Mylan hopes Disney can add new magic to its allergy-fighting kingdom. FiercePharmaMarketing story | Follow @CarlyHFierce
> Big Pharma, rejoice: China aims to speed up approvals for new meds. Story
> Merck's Keytruda ready for quick FDA action on big melanoma expansion. Report
> Boehringer trumpets Spiolto quality-of-life data as it looks for its niche in COPD. Article
Drug Delivery News
> BioDelivery snags new FDA approval for Onsolis after ditching Meda partnership. More
> Hydrogels: Study shows use in ulcerative colitis and Army invests in wound healing research. Report
> Checkmate Pharma gets $20M in Series A to develop cancer candidate with VLP platform. Story
> Cannabics Pharma's extended-release medical marijuana capsules available in Colorado. Item
> Intersect's steroid-releasing implant meets its endpoint in bid for expanded indication. Article
Pharma Manufacturing News
> FDA castigates three Mylan sterile drug plants in warning letter. News
> Hemispherx says plant upgrade will allow it to return its genital wart treatment to market. Item
> GSK resumes production at plant where Legionella bacteria was detected. Report
> Merck manufacturing shedding another 2,600 jobs. Story
> Novo Nordisk looks at building its first U.S. insulin plant. Article
Pharma Asia News
> More scrutiny for Japanese duodenoscope makers on notification failures. Report
> India's Lee Pharma turned down on CL challenge to AZ's Onglyza. Item
> Does China yuan devaluation mean more downbeat pharma earnings? Article
> Japan's Mitsui buys stake in India top drug wholesaler Keimed. Story
> Going private for WuXi PharmaTech opens dealmaking options. More